Table 1.

Incidence, onset time^*, and seriousness of anti-TB adverse drug reactions.

Type of ADRs	Minor ADRs (%)	Major ADRs (%)	Mean of onset time (range) days
Gastrointestinal disorders	114 (91.9)	10 (8.1)	19 (4–57)
Liver dysfunction	162 (80.6)	39 (19.4)	17 (12–68)
Allergic reactions	63 (73.3)	23 (26.7)	20 (6–45)
Flu-like reactions	76 (100)	0	5 (1–9)
Arthralgia	29 (85.3)	5 (14.7)	36 (23–55)
Hematologic disorders	3 (42.8)	4 (57.2)	52 (29–81)
Peripheral neuropathy	14 (81.4)	3 (17.6)	48 (38–74)
Renal impairment	1 (20)	4 (80)	32 (27–41)
Visual impairment	1 (16.7)	5 (83.3)	46 (34–72)
Ototoxicity	1 (14.3)	6 (85.7)	33 (20–54)
Total	464 (82.4)	99 (17.6)	19 (4–81)

^*It was from initiation of treatment. (It was the time that ADRs were found, not the exact time it happened.)